Prevent resisting the medicine price of malaria and sitting down again " The roller coaster "

Prevent resisting the medicine price of malaria and sitting down again " The roller coaster "
Prevent resisting the medicine price of malaria and sitting down again " The roller coaster "
The jumbo fluctuation of qinghaosu market that staff reporter Wang Dan started in 2004, cause qinghaosu's price amplitude to exceed 700%, and the purchasing price of Herba Artemisiae Annuae of our country has gone through the course rising and dropping suddenly and sharply. Novartis' pharmacy has born the great economic pressure as the main supplier who resists malaria treatment medicine. However, the efforts only according to an enterprise are obviously unable to meet the whole world to resist the demand that malaria medicine increases day by day. Some international organizations are taking measures actively, reduce the fluctuation against medicine price of malaria. July 16, cooperative agreement which Clinton foundation, malaria project special envoy and medicine chairman and concurrently CEO of Novartis of the United Nations have announced with 6 companies in the world together. 6 companies including China of China sets up the medicine company, he guides the medicine company, Callick of India belongs to medical chemical company, Cipla Company, IpcaLaboratories Company and Mangalam medicine company in Sri Lankan. According to this agreement, compound preparation of antimalarial agent qinghaosu - -The not decreasing amplitude of price of the quinoline of Herba Artemisiae Annuae amber ketone and A will exceed 30%, but the decreasing amplitude of price of its main raw materials qinghaosu will reach 70%. Clinton thinks, these companies promise to reduce the fluctuation rate of the market of medicines, and it is cheap since it offer sustainable medicines price,it last resisting by malaria treatment global to but and, economic effective direction last one steps great again. Reduce, resist the intersection of malaria and the intersection of medicine and the intersection of price and fluctuation, take action agreement that discuss and decide according to the intersection of Clinton and AIDS, the intersection of Indian and Ipca and the intersection of Cipla and with equal to or not less than a piece of 48 cents for each person to bind prices two company, offer a not quinoline compound preparation to the most frequently used resisting malaria medicines Herba Artemisiae Annuae amber ester and A, this price is lower than the current current price on market above 30%. Meanwhile, they, also in order to mean or be less than a current price of 91 cents for every people of Novartis, offer another commonly used resisting first ether - benzene fluorene alcohol of treatment medicines Artemisia of malaria. In the producers of these agreements in all participation, two Indian companies are active intermediate suppliers, they promise so as to below or is mean the price of the ceiling price, will win qinghaosu from the supplier qinghaosu, promise to supply patent medicine manufacturer with raw materials medicine at the optimum price at the same time; China set up medicine company and he guide medicine company promise with less than market price 70% ' Regard supreme price of 1100 dollars of the market / kilogram as the standard) Offer qinghaosu raw materials. Group's executive vice president InderSingh of the medicine accessibility of Clinton foundation says, the basic goal of this agreement is for reducing the fluctuation of the price. He explains, Clinton foundation does not participate in directly and purchase medicines, the agreement does not include the content that medicines are purchased either, its tactics lie in combining the whole of qinghaosu market, provide demand information for enterprise in the agreement frame to predict, help enterprises to reach the international quality criteria, and launch extensive cooperation with the international governments of non-governmental organizations, African countries; Make 6 enterprises participate in purchasing in the system several extant at cheap price, for example global the fund purchases system,etc.. It is introduced, WHO just purchases medicines under the frame of the fund of the whole world, then offer to some countries. The global fund is the biggest project used for resisting malaria in the world now, probably accounts for 2/ 3 that antimalarial agent is purchased in the whole year. Resist the intersection of malaria and the intersection of medicine and market expand 327% Clinton foundation release first use medicine the intersection of requirement forecasting and report jointly about global the intersection of qinghaosu and kind the near future. This report points out, if qinghaosus jointly use medicine the plan of the price subsidy can be implemented, global qinghaosus will jointly use medicine demand will double at least in the following 4 years, its growth rate may be up to 327%, it is estimated that is up to more than 400 million boxes. InderSingh showed, released one of 100 million people of antimalarial agent together in the whole world last year. But the real global person suffering from malaria may be well-above this figure, estimate 300 million - 500 million people in advance. It is very effective that there is malaria of drug therapy now, but the patient is bitten by the mosquito, may be again ill. So, the difference among actual demand and supply makes a plurality of government organizations, non-governmental organizations, international organizations throw into a large number of efforts, attempt to increase the supply against malaria medicine in the whole world. InderSingh introduce, the intersection of Herba Artemisiae Annuae and the intersection of amber and ketone and A the intersection of quinoline and compound the intersection of preparation and consumption last year up to 35 million - 40 million the intersection of people and copy already in the agreement, if prices of finished medicine are reduced 30% more, will increase 12 million people and get this medicine. The small subsidy policy of the African pilot project, in order to improve the accessibility against malaria medicine, Clinton foundation has implemented the measure for the pharmacy to make a reduction and replenish in Tanzania, in order to guarantee a patient can get cheap resisting malaria and uniting preparations. In a short period of 5 months, this pilot project exerted a positive influence in this country. Jointly containing qinghaosu preparation is from rising to 1% to exceed 50% in the market share of the trial zone, the retail price was reduced from 10 dollars to 0.5 dollars, children's accessibility against malaria treatment has increased by 60 times too. Clinton foundation will cooperate with Tanzanian government and other countries of Africa next year, popularize such small subsidy, it is expected that can help the patient of 6 million, but can benefit ten millions of patients in the whole Africa. Domestic enterprises expect well the representatives of Chinese enterprises express at the news briefing, qinghaosu industry rises and falls, the billow washes the sand, some enterprises have already been eliminated. The signature of this agreement will undoubtedly further improve the concentration degree of the industry. Having gone through the wind and waves of the market, a lot of domestic enterprises realize the sustainable development which keep the appropriate profit is the development trend of qinghaosu industry. So, it says that expectant to the future to add the malaria medicines low price of Clinton foundation and supply with two enterprises of China that ensure the new agreement. " in the past few years, patent medicine manufacturer and raw materials enterprise even Artemisia of qinghaosu of our country were agricultural to help to purify the market, have gone through the price from peak to low ebb and fluctuated. And this Clinton foundation relies on its global influence to join qinghaosu trade, we are expectant to the future. " He guides company's director, general manager Ms. Lin Ting is saying, the agreement is not to keep the price very low in 3 signing this time on day, have guaranteed there is a relatively stable profit in this industry chain in enterprises at first. Qinghaosu is that World Health Organization only approved resists specific drug of malaria, also China accords with the international standard and has independent intellectual property right and originality medicine of the international monopoly first. In 2004, World Health Organization resisted qinghaosus malaria medicines to classify as first-selected guidance and use medicine, qinghaosu is in short supply immediately. Until today, short 5 years, qinghaosu drew enterprises and increased from a dozen to over one hundred families too, the price of qinghaosu raw materials is like sitting down " Cross the mountain The car " ,From 150 dollars / kilogram to 1100 dollars / kilogram, fluctuating range is up to 700%. However, it is domestic qinghaosu industry, qinghaosu's raw materials stock reached 150 tons last year. Does Lin Ting say, with Clinton foundation? The garden invades and smokes �'s second Rice steamer firm �� Mou chew the intersection of clump and several broadleaf plants sigh mu Is �� high? Produce in the supply alliance which family's enterprises make up, guarantee enterprises can have a long and steady marketing channel in this way. In addition, this project has not only helped the patient of Africa also helped the Artemisia of China to be agricultural. "The lowest reach of the industry is the peasants of our country, they have really had plenty and lost, hope this agreement can let them have a more stable and more reliable income. " Lin Ting emphasizes, to guide the medicine company to him, this project is only a component of the industry of group company, and to qinghaosu, this project, it still belongs to a public service, so it hopes to cooperate with more overseas enterprises to join this agreement this time, open the international market. It is a leading enterprise of production of qinghaosu of our country that reduction does not increase risk Chongqing China to set up the medicine company, after just going through the patent infringement disturbance, signed the agreement with Clinton foundation this time, have undoubtedly opened a gate leading to the international market. Refer to the intersection of qinghaosu and the intersection of raw materials and price that agreement stipulate this, reduce 70%, Chongqing China set up the intersection of medicine company and the intersection of raw materials and the intersection of Division and general manager, bathe in the gill fungus of pool think to have no risk. "From the viewpoint of investor, conclude that should see the reference system in risk. " He says, the price of qinghaosu is probably 210- 220 dollars / kilogram on the market at present, and reduction is 70% on a basis of 1100 dollars / kilogram, the upper limit that the agreement stipulates is higher than the market price now, so there is no risk. Where is the price of upper limit stipulated in this agreement from and come? Bathe in the gill fungus of pool to explain, the officers of WHO and World Bank say at a lot of international conferences, under the condition of purchasing on a large scale, guarantee every year 300 million - 500 million people and a qinghaosu in the world unite the treatment, it is expected the price of preparation should be controlled about 1 dollar, and chase the layer to push to the raw materials instead, it is probably this price now. Moreover in 3 year in agreement, price fluctuate and exchange rate of RMB influence etc. with petroleum, qinghaosu raw materials' ceiling price can be consulted. Bathe in the gill fungus of pool say, China stands medicine companies only by promising the price offers the raw materials to the producer in the agreement, do not have responsibility and voluntary to offer and promise prices to enterprises outside the agreement. "Even in the agreement, we decide prices through the business negotiation too. " Referring to China sets up the reason to join this agreement this time, it shows one values this organization of Clinton foundation very much to bathe in the gill fungus of pool, had abundant experiences in the AIDS project in the past because of it, and there is much generality between two projects, so the possibility that this project succeeds will be very great. Second, can share industry's information within the coordinating mechanism, guide enterprise's science decision. "We do not want to repeat the big rise and big fall several years ago again! In addition, we have an opportunity to cooperate with American non-governmental organization through the agreement, popularize and propagate Chinese qinghaosu with the independent intellectual property right, this is a part of the tactics of our market too, it is the new opportunity that enterprises develop the international market. " It shows, China sets up the raw materials that medicine company is supplied to member in the agreement and is fewer than fifty percent of all raw materials of enterprise to bathe in the gill fungus of pool, so influence on gaining estimate in advance well. "But because of our understanding of this trade, antimalarial agent is the humanistic industry. In addition, it is only a component of our business, but not all. " The future market wants the tripartite equilibrium of many feet to look from the whole world, the marketing channel of qinghaosu is divided into a market of public service and part on the private market two. The market of public service accounts for more than eighty-percent, mainly purchased by WHO, the capital source is the global public interest organization. WHO emphasizes security and cost of medicines in choosing provider and order how to release, require the provider to supply the products with cost price. Novartis, as the biggest qinghaosu provider in the world, its amount of purchase reaches 2/3 of WHO, it is a leading enterprise of qinghaosu industry. This time why has not Novartis joined this agreement? The personage in the know reveals, it is not too violent that the agreement fluctuates for guaranteeing prices. A lot of producers can't resist the losses that prices fluctuate and bring over these years, and Novartis has never raised the price of finished medicine because the raw materials rises in price, so they are unnecessary temporarily joins this system. To a alone great current situation of qinghaosu industry Novartis at present, Lin Ting says, base on the premise that Clinton foundation medicines are replenished the plan to continue implementation, will produce the situation of the tripartite equilibrium of many feet with the enlargement of the market demand, increase of industry's concentration degree. It shows, with members' increase in the alliance in the future, the information sharing becomes reality to bathe in the gill fungus of pool, fluctuating, supplying the chains and ensuring will be beneficial to the price. It is believed that qinghaosu industry will develop towards steady, ripe direction.


|